Thursday, July 12, 2012

Complete Genomics stock up on new technology, still off 52-week high

The Mountain View-based company's(NASDAQ:GNOM) stock boost was tied to an announcement about technology for whole genome sequencing that it says dramatically improves accuracy, enables fully-phased genomes, and reduces the amount of DNA required for testing.
Complete Genomics stock still is off from near $14 per share a year ago and its 52-week high of $15.60. 

No comments:

Post a Comment